Artículos de revistas
Recommendations Of The Latin American Thyroid Society On Diagnosis And Management Of Differentiated Thyroid Cancer [recomendações Da Sociedade Latino-americana De Tireoide Para Diagnóstico E Manejo Do Carcinoma Diferenciado De Tireoide]
Registro en:
Arquivos Brasileiros De Endocrinologia E Metabologia. , v. 53, n. 7, p. 884 - 897, 2009.
42730
2-s2.0-70849127614
Autor
Pitoia F.
Ward L.
Wohllk N.
Friguglietti C.
Tomimori E.
Gauna A.
Camargo R.
Vaisman M.
Harach R.
Munizaga F.
Corigliano S.
Pretell E.
Niepomniszcze H.
Institución
Resumen
The aims of these recommendations were to develop clinical guidelines for evaluation and mana-gement of patients with differentiated thyroid cancer applicable to Latin American countries. The panel was composed by 13 members of the Latin American Thyroid Society (LATS) involved with research and management of thyroid cancer from different medical centers in Latin America. The recommendations were produced on the basis of the expert opinion of the panel with use of prin-ciples of Evidence-Based Medicine. Following a group meeting, a first draft based on evidences and the expert opinions of the panel was elaborated and, later, circulated among panel members, for further revision. After, this document was submitted to the LATS members, for commentaries and considerations, and, finally, revised and refined by the authors. The final recommendations presented in this paper represent the state of the art on management of differentiated thyroid cancer applied to all Latin American countries. 53 7 884 897 Harach, H.R., Ceballos, G.A., Thyroid cancer, thyroiditis and dietary iodine: A review based on the Salta, Argentina model (2008) Endocr Pathol, 19 (4), pp. 209-20 Pretell, E.A., Delange, F., Hostalek, U., Corigliano, S., Barreda, L., Higa, A.M., Iodine nutrition improves in Latin America (2004) Thyroid, 14 (8), pp. 595-604 Davies, L., Welch, H.G., Increasing incidence of thyroid cancer in the United States, 1973-2002 (2006) JAMA, 295 (18), pp. 2164-7 Harach, H.R., Franssila, K.O., Wasenius, V.M., Occult papillary carcinoma of the thyroid. A "normal" finding in Finland. A systematic autopsy study (1985) Cancer, 56 (3), pp. 531-8 Sobrinho-Simoes, M., Asa, S.L., Kroll, T.G., Follicular carcinoma (2004) Pathology and genetics of tumours of endocrine organs, pp. 67-72. , In: DeLellis RA, Lloyd RV, Heitz PU, Eng C (editors)., Lyon: WHO Classification of Tumours Foulkees, W.D., Kloos, R.T., Harach, H.R., li Volsi, V., Familial non-medullary thyroid cancer (2004) WHO classification of tumors pathology and genetics of tumors of endocrine organs, pp. 257-61. , In: DeLelis RA, Lloyd RV, Heitz PU, Eng C (editors)., Lyon: WHO Gauna, A., Gutiérrez, S., Miras, M., Niepomniszcze, H., Parma, R., Consenso argentino de carcinoma diferenciado de tiroides (2006) Rev Arg Endocrinol Metab, 43 (3), pp. 131-6 Maia, A.L., Ward, L.S., Carvalho, G.A., Graf, H., Maciel, R.M., Maciel, L.M., Thyroid nodules and differentiated thyroid cancer: Brazilian consensus (2007) Arq Bras Endocrinol Metabol, 51 (5), pp. 867-93 Hundahl, S.A., Fleming, I.D., Fremgen, A.M., Menck, H.R., A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 (1998) Cancer, 83 (12), pp. 2638-48 Deveci, M.S., Deveci, G., Livolsi, V.A., Gupta, P.K., Baloch, Z.W., Concordance between thyroid nodule sizes measured by ultrasound and gross pathology examination: Effect on patient management (2007) Diagn Cytopathol, 35 (9), pp. 579-83 Mathias-Guiu, X., Delelis, R.A., Moley, J.F., Medullary carcinoma (2004) Pathology and genetics of tumours of endocrine organs, pp. 86-91. , In: DeLellis RA, Lloyd RV, Heitz PU, Eng C (editors)., Lyon: WHO Classification of Tumours Farkas, E.A., King, T.A., Bolton, J.S., Fuhrman, G.M., A comparison of total thyroidectomy and lobectomy in the treatment of dominant thyroid nodules (2002) Am Surg, 68 (8), pp. 678-82 Hay, I.D., McConahey, W.M., Goellner, J.R., Managing patients with papillary thyroid carcinoma: Insights gained from the Mayo Clinic's experience of treating 2,512 consecutive patients during 1940 through 2000 (2002) Trans Am Clin Climatol Assoc, 113, pp. 241-60 Appetecchia, M., Scarcello, G., Pucci, E., Procaccini, A., Outcome after treatment of papillary thyroid microcarcinoma (2002) J Exp Clin Cancer Res, 21 (2), pp. 159-64 Bonnin, C., Trojani, M., Corcuff, J.B., Bonichon, F., Outcome of 111 thyroid papillary carcinomas. Retrospective study from 1953 to 1994. Experience of Bergonie Institute (1997) Ann Endocrinol (Paris), 58 (4), pp. 318-25 Satge, D., Grob, J.C., Pusel, J., Methlin, G., Thyroid microcarcinoma with a fatal outcome and 34 other unusually aggressive cases reported in the literature (1990) Arch Anat Cytol Pathol, 38 (4), pp. 143-51 Robbins, K.T., Clayman, G., Levine, P.A., Medina, J., Sessions, R., Shaha, A., Neck dissection classification update: Revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery (2002) Arch Otolaryngol Head Neck Surg, 128 (7), pp. 751-8 Shaha, A.R., Complications of neck dissection for thyroid cancer (2008) Ann Surg Oncol, 15 (2), pp. 397-9 Loh, K.C., Greenspan, F.S., Gee, L., Miller, T.R., Yeo, P.P., Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: A retrospective analysis of 700 patients (1997) J Clin Endocrinol Metab, 82 (11), pp. 3553-62 Mazzaferri, E.L., Jhiang, S.M., Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer (1994) Am J Med, 97 (5), pp. 418-28 Samaan, N.A., Schultz, P.N., Hickey, R.C., Goepfert, H., Haynie, T.P., Johnson, D.A., The results of various modalities of treatment of well differentiated thyroid carcinomas: A retrospective review of 1599 patients (1992) J Clin Endocrinol Metab, 75 (3), pp. 714-20 Sawka, A.M., Thephamongkhol, K., Brouwers, M., Thabane, L., Browman, G., Gerstein, H.C., Clinical review 170: A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer (2004) J Clin Endocrinol Metab, 89 (8), pp. 3668-76 Pellegriti, G., Scollo, C., Lumera, G., Regalbuto, C., Vigneri, R., Belfiore, A., Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: Study of 299 cases (2004) J Clin Endocrinol Metab, 89 (8), pp. 3713-20 Lakshmanan, M., Schaffer, A., Robbins, J., Reynolds, J., Norton, J., A simplified low iodine diet in I-131 scanning and therapy of thyroid cancer (1988) Clin Nucl Med, 13 (12), pp. 866-8 Park, H.M., Perkins, O.W., Edmondson, J.W., Schnute, R.B., Manatunga, A., Influence of diagnostic radioiodines on the uptake of ablative dose of iodine-131 (1991) Thyroid, 4 (1), pp. 49-54 Jeevanram, R.K., Shah, D.H., Sharma, S.M., Ganatra, R.D., Influence of initial large dose on subsequent uptake of therapeutic radioiodine in thyroid cancer patient (1986) Int J Rad Appl Instrum B, 13 (3), pp. 277-9 Rosario, P.W., Reis, J.S., Barroso, A.L., Rezende, L.L., Padrao, E.L., Fagundes, T.A., Efficacy of low and high 131I doses for thyroid remnant ablation in patients with differentiated thyroid carcinoma based on post-operative cervical uptake (2004) Nucl Med Commun, 25 (11), pp. 1077-81 Bal, C., Padhy, A.K., Jana, S., Pant, G.S., Basu, A.K., Prospective randomized clinical trial to evaluate the optimal dose of 131 I for remnant ablation in patients with differentiated thyroid carcinoma (1996) Cancer, 77 (12), pp. 2574-80 Johansen, K., Woodhouse, N.J., Odugbesan, O., Comparison of 1073 MBq and 3700 MBq iodine-131 in postoperative ablation of residual thyroid tissue in patients with differentiated thyroid cancer (1991) J Nucl Med, 32 (2), pp. 252-4 Ward, L.S., High-dose radioiodine outpatient therapy (2009) Arq Bras Endocrinol Metabol, 53 (3), pp. 301-2 Pacini, F., Ladenson, P.W., Schlumberger, M., Driedger, A., Luster, M., Kloos, R.T., Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: Results of an international, randomized, controlled study (2006) J Clin Endocrinol Metab, 91 (3), pp. 926-32 Tuttle, R.M., Brokhin, M., Omry, G., Martorella, A.J., Larson, S.M., Grewal, R.K., Recombinant human TSH-assisted radioactive iodine remnant ablation achieves short-term clinical recurrence rates similar to those of traditional thyroid hormone withdrawal (2008) J Nucl Med, 49 (5), pp. 764-70 Pilli, T., Brianzoni, E., Capoccetti, F., Castagna, M.G., Fattori, S., Poggiu, A., A comparison of 1850 (50 mCi) and 3700 MBq (100 mCi) 131-iodine administered doses for recombinant thyrotropin-stimulated postoperative thyroid remnant ablation in differentiated thyroid cancer (2007) J Clin Endocrinol Metab, 92 (9), pp. 3542-6 Chianelli, M., Todino, V., Graziano, F.M., Panunzi, C., Pace, D., Guglielmi, R., Low-activity (2.0 GBq 54 mCi) radioiodine post-surgical remnant ablation in thyroid cancer: Comparison between hormone withdrawal and use of rhTSH in low-risk patients (2009) Eur J Endocrinol, 160 (3), pp. 431-6 Hänscheid, H., Lassmann, M., Luster, M., Thomas, S.R., Pacini, F., Ceccarelli, C., Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: Procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal (2006) J Nucl Med, 47 (4), pp. 648-54 Rosário, P.W., Borges, M.A., Purisch, S., Preparation with recombinant human thyroid-stimulating hormone for thyroid remnant ablation with 131I is associated with lowered radiotoxicity (2008) J Nucl Med, 49 (11), pp. 1776-82 Fatourechi, V., Hay, I.D., Mullan, B.P., Wiseman, G.A., Eghbali-Fatourechi, G.Z., Thorson, L.M., Are posttherapy radioiodine scans informative and do they influence subsequent therapy of patients with differentiated thyroid cancer? (2000) Thyroid, 10 (7), pp. 573-7 Pujol, P., Daures, J.P., Nsakala, N., Baldet, L., Bringer, J., Jaffiol, C., Degree of thyrotropin suppression as a prognostic determinant in differentiated thyroid cancer (1996) J Clin Endocrinol Metab, 81 (12), pp. 4318-23 Parle, J.V., Maisonneuve, P., Sheppard, M.C., Boyle, P., Franklyn, J.A., Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: A 10-year cohort study (2001) Lancet, 358 (9285), pp. 861-5 Ronga, G., Filesi, M., Ventroni, G., Vestri, A.R., Signore, A., Value of the first serum thyroglobulin level after total thyroidectomy for the diagnosis of metastases from differentiated thyroid carcinoma (1999) Eur J Nucl Med, 26 (11), pp. 1448-52 Heemstra, K.A., Liu, Y.Y., Stokkel, M., Kievit, J., Corssmit, E., Pereira, A.M., Serum thyroglobulin concentrations predict disease-free remission and death in differentiated thyroid carcinoma (2007) Clin Endocrinol (Oxf), 66 (1), pp. 58-64 Spencer, C.A., Takeuchi, M., Kazarosyan, M., Wang, C.C., Guttler, R.B., Singer, P.A., Serum thyroglobulin autoantibodies: Prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma (1998) J Clin Endocrinol Metab, 83 (4), pp. 1121-7 Haugen, B.R., Ridgway, E.C., McLaughlin, B.A., McDermott, M.T., Clinical comparison of whole-body radioiodine scan and serum thyroglobulin after stimulation with recombinant human thyrotropin (2002) Thyroid, 12 (1), pp. 37-43 Cailleux, A.F., Baudin, E., Travagli, J.P., Ricard, M., Schlumberger, M., Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer? (2000) J Clin Endocrinol Metab, 85 (1), pp. 175-8 David, A., Blotta, A., Rossi, R., Zatelli, M.C., Bondanelli, M., Roti, E., Clinical value of different responses of serum thyroglobulin to recombinant human thyrotropin in the follow-up of patients with differentiated thyroid carcinoma (2005) Thyroid, 15 (2), pp. 267-73 Baudin, E., Do Cao, C., Cailleux, A.F., Leboulleux, S., Travagli, J.P., Schlumberger, M., Positive predictive value of serum thyroglobulin levels, measured during the first year of follow-up after thyroid hormone withdrawal, in thyroid cancer patients (2003) J Clin Endocrinol Metab, 88 (3), pp. 1107-11 Spencer, C.A., Bergoglio, L.M., Kazarosyan, M., Fatemi, S., Lopresti, J.S., Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with differentiated thyroid carcinomas (2005) J Clin Endocrinol Metab, 90 (10), pp. 5566-75 Pacini, F., Molinaro, E., Castagna, M.G., Agate, L., Elisei, R., Ceccarelli, C., Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma (2003) J Clin Endocrinol Metab, 88 (8), pp. 3668-73 Leboulleux, S., Girard, E., Rose, M., Travagli, J.P., Sabbah, N., Caillou, B., Ultrasound criteria of malignancy for cervical lymph nodes in patients followed up for differentiated thyroid cancer (2007) J Clin Endocrinol Metab, 92 (9), pp. 3590-4 Liel, Y., Preparation for radioactive iodine administration in differentiated thyroid cancer patients (2002) Clin Endocrinol (Oxf), 57 (4), pp. 523-7 Golger, A., Fridman, T.R., Eski, S., Witterick, I.J., Freeman, J.L., Walfish, P.G., Three-week thyroxine withdrawal thyroglobulin stimulation screening test to detect low-risk residual/recurrent well-differentiated thyroid carcinoma (2003) J Endocrinol Invest, 26 (10), pp. 1023-31 Haugen, B.R., Pacini, F., Reiners, C., Schlumberger, M., Ladenson, P.W., Sherman, S.I., A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer (1999) J Clin Endocrinol Metab, 84 (11), pp. 3877-85 Helal, B.O., Merlet, P., Toubert, M.E., Franc, B., Schvartz, C., Gauthier-Koelesnikov, H., Clinical impact of (18)F-FDG PET in thyroid carcinoma patients with elevated thyroglobulin levels and negative (131)I scanning results after therapy (2001) J Nucl Med, 42 (10), pp. 1464-9 Chin, B.B., Patel, P., Cohade, C., Ewertz, M., Wahl, R., Ladenson, P., Recombinant human thyrotropin stimulation of fluoro-D-glucose positron emission tomography uptake in well-differentiated thyroid carcinoma (2004) J Clin Endocrinol Metab, 89 (1), pp. 91-5 Schlumberger, M., Mancusi, F., Baudin, E., Pacini, F., 131I therapy for elevated thyroglobulin levels (1997) Thyroid, 7 (2), pp. 273-6 Schlumberger, M., Tubiana, M., de Vathaire, F., Hill, C., Gardet, P., Travagli, J.P., Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma (1986) J Clin Endocrinol Metab, 63 (4), pp. 960-7 Schlumberger, M., Hitzel, A., Toubert, M.E., Corone, C., Troalen, F., Schlageter, M.H., Comparison of seven serum thyroglobulin assays in the follow-up of papillary and follicular thyroid cancer patients (2007) J Clin Endocrinol Metab, 92 (7), pp. 2487-95 Smallridge, R.C., Meek, S.E., Morgan, M.A., Gates, G.S., Fox, T.P., Grebe, S., Monitoring thyroglobulin in a sensitive immunoassay has comparable sensitivity to recombinant human tsh-stimulated thyroglobulin in follow-up of thyroid cancer patients (2007) J Clin Endocrinol Metab, 92 (1), pp. 82-7 Maciel, R.M., Will the thyroglobulin assay with lower functional sensitivity whilst the patients are on L-T4 treatment replace the TSH-stimulated thyroglobulin assay in the follow-up of patients with differentiated thyroid cancer? (2007) Arq Bras Endocrinol Metabol, 51 (5), pp. 862-6 de Keizer, B., Brans, B., Hoekstra, A., Zelissen, P.M., Koppeschaar, H.P., Lips, C.J., Tumour dosimetry and response in patients with metastatic differentiated thyroid cancer using recombinant human thyrotropin before radioiodine therapy (2003) Eur J Nucl Med Mol Imaging, 30 (3), pp. 367-73 Pitoia, F., Tamer, E.E., Schere, D.B., Passerieu, M., Bruno, O.D., Niepomniszcze, H., Usefulness of recombinant human TSH aided radioiodine doses administered in patients with differentiated thyroid carcinoma (2006) Medicina (B Aires), 66 (2), pp. 125-30 Luster, M., Lippi, F., Jarzab, B., Perros, P., Lassmann, M., Reiners, C., rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: A comprehensive review (2005) Endocr Relat Cancer, 12 (1), pp. 49-64 Jentzen, W., Freudenberg, L., Eising, E.G., Sonnenschein, W., Knust, J., Bockisch, A., Optimized 124I PET dosimetry protocol for radioiodine therapy of differentiated thyroid cancer (2008) J Nucl Med, 49 (6), pp. 1017-23 Koong, S.S., Reynolds, J.C., Movius, E.G., Keenan, A.M., Ain, K.B., Lakshmanan, M.C., Lithium as a potential adjuvant to 131I therapy of metastatic, well differentiated thyroid carcinoma (1999) J Clin Endocrinol Metab, 84 (3), pp. 912-6 Shimaoka, K., Schoenfeld, D.A., Dewys, W.D., Creech, R.H., Deconti, R., A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma (1985) Cancer, 56 (9), pp. 2155-60 Pennell, N.A., Daniels, G.H., Haddad, R.I., Ross, D.S., Evans, T., Wirth, L.J., A phase II study of gefitinib in patients with advanced thyroid cancer (2008) Thyroid, 18 (3), pp. 317-23 Sherman, S.I., Wirth, L.J., Droz, J.P., Hofmann, M., Bastholt, L., Martins, R.G., Motesanib Cancer Study Group. Motesanib Diphosphate in progressive differentiated thyroid cancer (2008) N Engl J Med, 3 (1), pp. 31-42 Gupta-Abramson, V., Troxel, A.B., Nellore, A., Puttaswamy, K., Redlinger, M., Ransone, K., Phase II trial of sorafenib in advanced thyroid cancer (2008) J Clin Oncol, 26 (29), pp. 4714-9 Cohen, E.E., Rosen, L.S., Vokes, E.E., Kies, M.S., Forastiere, A.A., Worden, F.P., Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: Results from a phase II study (2008) J Clin Oncol, 26 (29), pp. 4708-13 Ain, K.B., Lee, C., Williams, K.D., Phase II trial of thalidomide for therapy of radiodine-unresponsive and rapidly progressive thyroid carcinomas (2007) Thyroid, 17 (7), pp. 663-70 Hung, W., Sarlis, N.J., Current controversies in the management of pediatric patients with well-differentiated nonmedullary thyroid cancer: A review (2002) Thyroid, 12 (8), pp. 683-702 Iorcansky, S., Herzovich, V., Qualey, R.R., Tuttle, R.M., Serum thyrotropin (TSH) levels after recombinant human TSH injections in children and teenagers with papillary thyroid cancer (2005) J Clin Endocrinol Metab, 90 (12), pp. 6553-5 Vini, L., Hyer, S., Pratt, B., Harmer, C., Management of differentiated thyroid cancer diagnosed during pregnancy (1999) Eur J Endocrinol, 140 (5), pp. 404-6